Page 19 - டெட்ராய்ட் சிம்பொனி ஆர்கெஸ்ட்ரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Darlene Soave Joins Cell Source s Board of Directors News provided by Share this article Share this article NEW YORK, April 1, 2021 /PRNewswire/ Cell Source, Inc. (OTC: CLCS) ( Cell Source or the Company ), is the world leader in Veto Cell based innovative immunotherapy and today announced that Darlene Soave has been appointed to the Company s Board of Directors, effective March 25, 2021.  Veto Cells, in different mouse models, have shown that they have the potential to safely facilitate mismatched donor stem cell (e.g. bone marrow) transplants and organ transplants. In addition, in preclinical trials, Veto Cells have shown that they can durably treat malignant and non-malignant blood diseases through active immune response management.

United statesDetroit historicalMichael briolaYair reisnerDennis brownItamar shimratAdg groupCompany board of directorsCompany contactSoave enterprisesInvestor resource centerCell source incCell source investor resource centerPrnewswire cell source incBoard of directors soave enterprisesAdvisory group